FDA-CSS-1238961_0001.pdf

AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT 1. CONTRACT ID CODE PAGE OF PAGES

1 2

2. AMENDMENT/MODIFICATION NO.

3. EFFECTIVE DATE

06/24/2021

4. REQUISITION/PURCHASE REQ. NO.

1238961

5. PROJECT NO. (If applicable)

6. ISSUED BY CODE HFT-323 7. ADMINISTERED BY (If other than Item 6) CODE HFT-322

FDA/OO/OFBA/OAGS/DAP

OAGS - Field Operations Branch ATTN: Jennifer Johnson 3900 NCTR Road, Bldg. 50, Rm. 429 Jefferson AR 72079

FDA/OO/OFBA/OAGS/DAP

OAGS - ACQUISITION SERVICES

3900 NCTR ROAD

JEFFERSON AR 72079

8. NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code)

(x) 9A. AMENDMENT OF SOLICITATION NO.

FDA-CSS-1238961

x 9B. DATED (SEE ITEM 11)

10A. MODIFICATION OF CONTRACT/ORDER NO.

10B. DATED (SEE ITEM 13)

CODE FACILITY CODE

11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

x The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers x is extended, is not extended.

Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods: (a) By completing

Items 8 and 15, and returning 1 copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted; or (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGEMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by letter or electronic communication, provided each letter or electronic communication makes reference to the solicitation and this amendment and is received prior to the opening hour and date specified.

12. ACCOUNTING AND APPROPRIATION DATA (If required)

13. THIS ITEM ONLY APPLIES TO MODIFICATION OF CONTRACTS/ORDERS. IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.

CHECK ONE A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT

ORDER NO. IN ITEM 10A.

B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation data, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).

C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:

D. OTHER (Specify type of modification and authority)

E. IMPORTANT: Contractor is not is required to sign this document and return copies to the issuing office.

14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

1. The purpose of the amendment is to:

a. Extend the "Offer Due Date/Time" to 12:00 pm Central Time (CT), 08 July 2021.

b. Schedule a site visit for 9:00 am CT, 29 June 2021.

2. All other terms and conditions remain unchanged.

Except as provided herein, all terms and conditions of the document referenced in Item 9 A or 10A, as heretofore changed, remains unchanged and in full force and effect.

15A. NAME AND TITLE OF SIGNER (Type or print) 16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)

Jennifer L. Johnson

15B. CONTRACTOR/OFFEROR

(Signature of person authorized to sign)

15C. DATE SIGNED 16B. UNITED STATES OF AMERICA

(Signature of Contracting Officer)

16C. DATE SIGNED

Previous edition unusable STANDARD FORM 30 (REV. 11/2016) Prescribed by GSA FAR (48 CFR) 53.243

SECTION SF 30 BLOCK 14 CONTINUATION PAGE

The following items are applicable to this modification:

SOLICITATION/CONTRACT FORM

A. The required response date/time has changed from 28 June 2021; 12:00 PM (CT) to 08 July 2021; 12:00 PM (CT).

*Offers shall submit their response to FDA-CSS-1238961 in electronic format by email to the Contract Specialist, Jennifer Johnson, at jennifer.johnson3@fda.hhs.gov ensuring “Offer under Solicitation No. FDA-CSS-1238961” appears in the subject line.

B. A site visit is scheduled for 9:00 AM (CT) on June 29, 2021. Offerors are highly encouraged to attend. Space is limited due to social distancing requirements. Each Contractor is limited to two attendees. Notification of intent to attend plus a completed "Attachment 1- Jefferson Labs (JL) Visitors COVID-19 Screening Questionnaire" for each attendee must be sent to Jennifer Johnson at jennifer.johnson3@fda.hhs.gov no later than 7:00 AM (CT) on June 28, 2021.

C. Questions concerning this requirement are required in writing to jennifer.johnson3@fda.hhs.gov by 10:00 am (CT) on June 30, 2021. *No other questions will be entertained after this suspense.

mailto:jennifer.johnson3@fda.hhs.gov mailto:jennifer.johnson3@fda.hhs.gov mailto:jennifer.johnson3@fda.hhs.gov